Loading XENE charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading XENE comparable companies…
| XENEXenon Pharmaceuticals Inc.(opens in a new tab) | $3.73B | $0.00B | −100.0% | — | — | — | — |
|---|---|---|---|---|---|---|---|
| AAPGAscentage Pharma Group International(opens in a new tab) | — | $0.08B | −41.4% | 91.5% | — | — | — |
| ABBVAbbVie Inc.(opens in a new tab) | $522.12B | $64.39B | +10.4% | 71.5% | 26.2% | 8.11× | 83.3× |
| ABCLAbCellera Biologics Inc.(opens in a new tab) | $3.75B | $0.07B | +101.3% | — | −340.3% | 56.66× | — |
| ABEOAbeona Therapeutics Inc.(opens in a new tab) | $0.25B | $0.03B | — | 67.1% | −327.6% | 9.75× | — |
| Medianpeers, excl. XENE | $3.75B | $0.07B | +10.4% | 71.5% | −327.6% | 9.75× | 83.3× |